文献速递乳腺癌放疗放疗物理与技术

深吸气屏气能否延长生命?乳腺癌放疗后缺血性心脏病的个体风险估计

Does deep inspiration breath-hold prolong life? Individual risk estimates of ischaemic heart disease after breast cancer radiotherapy.
PubMed 文献 · Radiother Oncol · 2018-08-07

该比较建模研究基于前瞻性SAVE-HEART研究的89例左侧早期乳腺癌患者,为每例患者分别制定自由呼吸和深吸气屏气的三维适形治疗计划,并估算辐射诱发的缺血性心脏病死亡风险。深吸气屏气使平均心脏剂量较自由呼吸降低35%(四分位距23-46%),辐射诱发的缺血性心脏病死亡导致的平均预期寿命损失在自由呼吸为0.11年、深吸气屏气为0.07年。作者认为深吸气屏气技术应提供给所有左侧乳腺癌患者,而肿瘤预后良好、平均心脏剂量高或基线缺血性心脏病风险高的患者获益最大,且与年龄无关。

要点

  • 深吸气屏气使平均心脏剂量较自由呼吸降低35%(四分位距23-46%)。
  • 辐射诱发缺血性心脏病死亡的平均预期寿命损失:自由呼吸0.11年 vs 深吸气屏气0.07年。
  • 肿瘤预后良好、平均心脏剂量高或基线缺血性心脏病风险高的患者寿命损失减少更明显,且与年龄无关。

核心结论

  • 作者认为,深吸气屏气技术应提供给所有左侧乳腺癌患者,但肿瘤预后良好、平均心脏剂量高或基线缺血性心脏病风险高的患者预期获益最大,且与年龄无关。

研究设计与样本

  • 比较建模研究,基于前瞻性SAVE-HEART研究纳入的89例左侧早期乳腺癌患者,为每例患者分别制定自由呼吸和深吸气屏气的三维适形治疗计划,并基于预期生存、个体缺血性心脏病危险因素和相对辐射诱发风险估算缺血性心脏病死亡风险。

主要发现

  • 使用深吸气屏气时,平均心脏剂量较自由呼吸降低35%(四分位距23-46%)。
  • 辐射诱发缺血性心脏病死亡导致的平均预期寿命损失在自由呼吸为0.11年,在深吸气屏气为0.07年。
  • 在肿瘤预后良好的患者中,预期寿命损失与治疗时年龄显著无关。
  • 深吸气屏气使高基线风险患者的预期寿命损失减少更明显:上四分位组0.08年 vs 下四分位组0.02年。
  • 肿瘤预后良好者中,无淋巴结受累患者预期寿命损失减少0.05年 vs 有淋巴结受累患者0.02年;自由呼吸平均心脏剂量>3 Gy者减少0.09年 vs <1.5 Gy者0.02年。

临床怎么用

  • 作者认为,深吸气屏气技术应提供给所有左侧乳腺癌患者。
  • 作者指出,肿瘤预后良好、平均心脏剂量高或基线缺血性心脏病风险高的患者预期获益最大,且与年龄无关。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Aim of the current comparative modelling study was to estimate the individual radiation-induced risk for death of ischaemic heart disease (IHD) under free breathing (FB) and deep inspiration breath-hold (DIBH) in a real-world population. MATERIALS AND METHODS: Eighty-nine patients with left-sided early breast cancer were enrolled in the prospective SAVE-HEART study. For each patient three-dimensional conformal treatment plans were created in FB and DIBH and corresponding radiation-induced risks of IHD mortality were estimated based on expected survival, individual IHD risk factors and the relative radiation-induced risk. RESULTS: With the use of DIBH, mean heart doses were reduced by 35% (interquartile range: 23-46%) as compared to FB. Mean expected years of life lost (YLL) due to radiation-induced IHD mortality were 0.11 years in FB, and 0.07 years in DIBH. YLL were remarkably independent of age at treatment in patients with a favourable tumour prognosis. DIBH led to more pronounced reductions in YLL in patients with high baseline risk (0.08 years for upper vs 0.02 years for lower quartile), with favourable tumour prognosis (0.05 years for patients without vs 0.02 years for those with lymph-node involvement), and in patients with high mean heart doses in FB (0.09 years for doses >3 Gy vs 0.02 years for doses <1.5 Gy). CONCLUSION: Ideally, the DIBH technique should be offered to all patients with left-sided breast cancer. However, highest benefits are expected for patients with a favourable tumour prognosis, high mean heart dose or high baseline IHD risk, independent of their age.

来源:Radiother Oncol,查看原文。版权归原作者所有。

引用

  1. Simonetto C, Eidemüller M, Gaasch A, et al. Does deep inspiration breath-hold prolong life? Individual risk estimates of ischaemic heart disease after breast cancer radiotherapy. Radiother Oncol. 2018. PMID: 30097250. doi:10.1016/j.radonc.2018.07.024

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。